Skip to content
sellNotable cluster of 4

Atomico Advisors IV, Ltd. sold $85M of HNGE

owner at Hinge Health, Inc.. 2,651,103 shares at an average of $32.00, traded May 23, 2025, filed May 27, 2025.

Warning score
72
Value
$85M
2,651,103 shares
Holdings after
0
-100% from before
From 52-week low
+7%
low $37.56, close $40.16
From 52-week high
0%
high $40.16, as of May 23, 2025

Score components

  • Role
    10% owner
    +12
  • Trade size
    $84.8M at market
    +25
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +6.7%, 3m +30.9%, 6m +14.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HNGEOct 12, 2026 · close 104.82
Since filing May 27, 2025: +148.8%SPY +33.8% · excess +115.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000950170-25-077936, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 23, 2025CConversion
Class A Common Stockindirect: See footnotes
+2,651,103--2,651,103May 27, 2025
May 23, 2025SOpen-market sale
Class A Common Stockindirect: See footnotes
-2,651,103$32.00$85M0May 27, 2025
May 23, 2025JOther
Series A-2 Preferred Stockderivativeindirect: See footnotes
-4,830,917--0May 27, 2025
May 23, 2025JOther
Series B Preferred Stockderivativeindirect: See footnotes
-2,245,545--0May 27, 2025
May 23, 2025JOther
Series C Preferred Stockderivativeindirect: See footnotes
-1,175,333--0May 27, 2025
May 23, 2025JOther
Series C-1 Preferred Stockderivativeindirect: See footnotes
-602,298--0May 27, 2025
May 23, 2025JOther
Series D Preferred Stockderivativeindirect: See footnotes
-510,073--0May 27, 2025
May 23, 2025JOther
Class B Common Stockderivativeindirect: See footnotes
+9,364,166--9,364,166May 27, 2025
May 23, 2025CConversion
Class B Common Stockderivativeindirect: See footnotes
-2,651,103--6,713,063May 27, 2025

Related signals

Other insiders at Hinge Health, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
Pro nowfree Oct 20, 2026
HNGEsell 310b5-1
Hinge Health, Inc.
James Budge
Chief Financial Officer
$4.9M
47,720 shares
-14%
Pro nowfree Oct 20, 2026
HNGEsell 310b5-1
Hinge Health, Inc.
Gabriel M.I. Mecklenburg
director, other
$21M
200,000 shares
-100%
56Moderate
HNGEsell 310b5-1
Hinge Health, Inc.
Daniel Antonio Perez
CEO & Co-Founder
$411k
4,100 shares
-100%
40Moderate
HNGEsell 410b5-1
Hinge Health, Inc.
James Pursley
President
$3.1M
33,000 shares
-5%
55Moderate
HNGEsell 410b5-1
Hinge Health, Inc.
Gabriel M.I. Mecklenburg
director, other
$14M
150,000 shares
-100%
55Moderate
HNGEsell 410b5-1
Hinge Health, Inc.
Gabriel M.I. Mecklenburg
director, other
$22M
250,000 shares
-100%
47Moderate
HNGEsell 410b5-1
Hinge Health, Inc.
James Budge
Chief Financial Officer
$5.0M
55,561 shares
-14%
65Notable
HNGEsell 410b5-1
Hinge Health, Inc.
Daniel Antonio Perez
CEO & Co-Founder
$22M
250,000 shares
-172%
33Weak
HNGEsell 210b5-1
Hinge Health, Inc.
James Pursley
President
$2.9M
33,000 shares
-4%
33Weak
HNGEsell 2
Hinge Health, Inc.
Kristina M Leslie
director
$106k
1,200 shares
-4%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Atomico Advisors IV, Ltd. sold $85M of HNGE | InsiderTell